{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Hamburger Menu
Catalog
EP on EP Episode 44 - QTc Monitoring with Drug The ...
EP on EP Episode 44 - QTc Monitoring with Drug Therapy During COVID-19
Description
Eric N. Prystowsky, MD, FHRS, takes EP on EP online with Michael John Ackerman, MD, PhD to discuss QTc Monitoring with Drug Therapy During COVID-19.
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
No Credit Offered
×
EP on EP Episode 44 - QTc Monitoring with Drug Therapy During COVID-19 Course List
Recommended
Learning Activity Title
Learning Activity Title
Learning Activity Title
HRS 2020 Science- May
Multiple Credits
FREE
(40)
Learning Activity Title
Learning Activity Title
Learning Activity Title
EP on EP Episode 59: Pacing-Induced Cardiomyopathy
No Credit
FREE
(2)
Learning Activity Title
Learning Activity Title
Learning Activity Title
EP on EP Episode 52 - Device Detected AF & Stroke Risk
No Credit
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
EP on EP Episode 55 - Risk Stratification for SCD Asymptomatic Ventricular Pre-Excitation Patients
No Credit
FREE
(1)
Learning Activity Title
Learning Activity Title
Learning Activity Title
EP on EP Episode 40 - Update on LAA Closure
No Credit
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
EP on EP Episode 58 - AFib Ablation in CHF Patients
No Credit
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
EP101 - A Program for Incoming EP Fellows
No Credit
FREE
(20)
Learning Activity Title
Learning Activity Title
Learning Activity Title
2019 Focused Update of the 2014 Guideline for Management of Patients with Atrial Fibrillation
No Credit
FREE
(7)
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Forgot Password
Heart Rhythm Society
1325 G Street NW, Suite 400
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English